NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|270486282|gb|ACZ82922|]
View 

recombination activating protein 2, partial [Xenopus laevis]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
RAG2 super family cl28748
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
21-325 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


The actual alignment was detected with superfamily member pfam03089:

Pssm-ID: 427128  Cd Length: 339  Bit Score: 600.57  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282   21 KNNDLKLRPTTFTNDSCYLPPLRHPAVCSFSASQGGEITQYLIHGGKTPNNEISHKLYIMTMAFPVNKRFSLCCSEKDLA 100
Cdd:pfam03089   1 KKNELKLRPASFSNDSCYLPPLRYPAICTLKPSDEGEKEQYLIHGGKTPNNELSDKLYIMSLDSKGNKKVTLRCTEKELV 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  101 GDVPEARYGHSMNVVFSRGKTAVVMFGGRSYMPLNQRTTENWNNVIDCEPLVYLIDLQFGCSTSF*LRELQDGLSFHVSL 180
Cdd:pfam03089  81 GDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQRTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  181 ARNDTVYIFGGHSLGNNFRPPNVYKIKVDLPLGSPAVSCTVINSKLSFSSSIVTQTSPDEFVIVGGYESDSQKRLICNGV 260
Cdd:pfam03089 161 ARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPAVSCTVLPGGISVSSAIVTQTGSHEFVIVGGYQSESQKRMVCNTV 240
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 270486282  261 FLDDETIDIQEIETPDWAGEIKHSKTWFGADMGKGAVLFGIPVDNKHQSTDcSFFFYILNFGDND 325
Cdd:pfam03089 241 VLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKGAVLLGIPGDNKQLPSD-ANYFYQLNFGEDE 304
 
Name Accession Description Interval E-value
RAG2 pfam03089
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
21-325 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


Pssm-ID: 427128  Cd Length: 339  Bit Score: 600.57  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282   21 KNNDLKLRPTTFTNDSCYLPPLRHPAVCSFSASQGGEITQYLIHGGKTPNNEISHKLYIMTMAFPVNKRFSLCCSEKDLA 100
Cdd:pfam03089   1 KKNELKLRPASFSNDSCYLPPLRYPAICTLKPSDEGEKEQYLIHGGKTPNNELSDKLYIMSLDSKGNKKVTLRCTEKELV 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  101 GDVPEARYGHSMNVVFSRGKTAVVMFGGRSYMPLNQRTTENWNNVIDCEPLVYLIDLQFGCSTSF*LRELQDGLSFHVSL 180
Cdd:pfam03089  81 GDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQRTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  181 ARNDTVYIFGGHSLGNNFRPPNVYKIKVDLPLGSPAVSCTVINSKLSFSSSIVTQTSPDEFVIVGGYESDSQKRLICNGV 260
Cdd:pfam03089 161 ARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPAVSCTVLPGGISVSSAIVTQTGSHEFVIVGGYQSESQKRMVCNTV 240
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 270486282  261 FLDDETIDIQEIETPDWAGEIKHSKTWFGADMGKGAVLFGIPVDNKHQSTDcSFFFYILNFGDND 325
Cdd:pfam03089 241 VLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKGAVLLGIPGDNKQLPSD-ANYFYQLNFGEDE 304
 
Name Accession Description Interval E-value
RAG2 pfam03089
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
21-325 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


Pssm-ID: 427128  Cd Length: 339  Bit Score: 600.57  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282   21 KNNDLKLRPTTFTNDSCYLPPLRHPAVCSFSASQGGEITQYLIHGGKTPNNEISHKLYIMTMAFPVNKRFSLCCSEKDLA 100
Cdd:pfam03089   1 KKNELKLRPASFSNDSCYLPPLRYPAICTLKPSDEGEKEQYLIHGGKTPNNELSDKLYIMSLDSKGNKKVTLRCTEKELV 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  101 GDVPEARYGHSMNVVFSRGKTAVVMFGGRSYMPLNQRTTENWNNVIDCEPLVYLIDLQFGCSTSF*LRELQDGLSFHVSL 180
Cdd:pfam03089  81 GDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQRTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 270486282  181 ARNDTVYIFGGHSLGNNFRPPNVYKIKVDLPLGSPAVSCTVINSKLSFSSSIVTQTSPDEFVIVGGYESDSQKRLICNGV 260
Cdd:pfam03089 161 ARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPAVSCTVLPGGISVSSAIVTQTGSHEFVIVGGYQSESQKRMVCNTV 240
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 270486282  261 FLDDETIDIQEIETPDWAGEIKHSKTWFGADMGKGAVLFGIPVDNKHQSTDcSFFFYILNFGDND 325
Cdd:pfam03089 241 VLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKGAVLLGIPGDNKQLPSD-ANYFYQLNFGEDE 304
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH